Diagnosing MS Using MRI
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127. 8. Dalton CM, Brex PA, Miszkiel KA, Hickman SJ, MacManus DG, Plant GT et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002; 52: 47–53. 9. Tintoré M, Rovira A, Rio J, Nos C, Grive E, Sastre-Garriga J et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003; 60: 27–30. 10. Korteweg T, Tintore M, Uitdehaag B, Rovira A, Frederiksen J, Miller D et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2006; 5: 221–227. 11. Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH et al. Treatment with interferon beta1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006; 67: 1242–1249. 12. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernandez O et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001; 357: 1576–1582. 13. Jacobs LD, Beck RW, Simon JH,
●
Kinkel RP, Brownscheidle CM, Murray TJ et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000; 343: 898–904. 14. Janssens AC, de Boer JB, Kalkers NF, Passchier J, van Doorn PA, Hintzen RQ. Patients with multiple sclerosis prefer early diagnosis. Eur J Neurol 2004; 11: 335–337. 15. Dalton CM, Brex PA, Miszkiel KA, Fernando K, MAcManus DG, Plant GT et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 2003; 53: 673–676. 16. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005; 58: 840–846. 17. Bot JC, Barkhof F, Nijeholt G, van Schaardenburg D, Voskuyl AE, Ader HJ et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 2002; 223: 46–56. 18. Bot JC, Barkhof F, Polman CH, Lycklama a Nijeholt GJ, de Groot V, Bergers E et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004; 62: 226–233. 19. Korteweg T, Barkhof F,
Uitdehaag BM, Polman CH. How to use spinal cord magnetic resonance imaging in the McDonald diagnostic criteria for multiple sclerosis. Ann Neurol 2005; 57: 606–607. 20. Dalton CM, Brex PA, Miszkiel KA, Fernando K, MacManus DG, Plant GT et al. Spinal cord MRI in clinically isolated optic neuritis. J Neurol Neurosurg Psychiatry 2003; 74: 1577–1580. 21. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485–1489. 22. Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M et al. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003; 61: 602–611. 23. Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158–164. 24. Eriksson M, Andersen O, Runmarker B. Long-term follow up of patients with clinically isolated syndromes, relapsing–remitting and secondary progressive multiple sclerosis. Mult Scler 2003; 9: 260–274. 25. Miller DH, Filippi M, Fazekas F, Frederiksen JL, Matthews PM,
●
Notes for Authors Aims and Scope
Montalban X et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol 2004; 56: 273–278. 26. Poser CM, Brinar VV. Problems with diagnostic criteria for multiple sclerosis. Lancet 2001; 358: 1746–1747. 27. Nielsen JM, Korteweg T, Barkhof F, Uitdehaag BM, Polman CH. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol 2005; 58: 781–783. 28. Uitdehaag BM, Kappos L, Bauer L, Freedman MS, Miller D, Sandbrink R et al. Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization. Mult Scler 2005; 11: 227–231. 29. Zipoli V, Portaccio E, Siracusa G, Pracucci G, Sorbi S, Amato MP. Interobserver agreement on Poser’s and the new McDonald’s diagnostic criteria for multiple sclerosis. Mult Scler 2003; 9: 481–485. 30. Korteweg T, Uitdehaag BM, Knol DL, Smithuis RH, Algra PR, de Vries C et al. Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis. Eur Radiol 2007; 17: 67–71. 31. Swanton JK, Fernando KT, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT et al. Modification of MRI criteria for MS in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006; 77: 830–833.
Notes for Authors
The journal is aimed primarily at clinical neurologists, researchers and academics, while it is also read by immunologists,
rehabilitation
specialists,
MS
nurses,
psychologists, MS society workers and policy makers.
The International MS Journal is the journal of the MS Forum. It publishes topical reviews, conference reports, news and views
Manuscript Submission
on all aspects of multiple sclerosis (MS). Feedback on the
Articles should be written in English and supplied in
topics covered or that reflects personal experience is
electronic format, via e-mail, to CMP. Please ensure that the
encouraged and may be considered as topics for future
primary author’s contact details, including telephone, fax
publication. The International MS Journal is a forum for
and e-mail address, are clearly indicated on the title page.
international communication and interaction in which
Also, please ensure that you retain a hard copy of the text
awareness of current opinion, new ideas and developments in
in addition to the electronic version. Manuscripts should be
MS will be presented. Ultimately, it is hoped that The
sent to:
International MS Journal will serve to improve the quality of treatment and care available to patients. The International MS
Jo Rogerson, Editorial Administrator
Journal is published three times a year by Cambridge Medical
International MS Journal
Publications (CMP). Copyright of published material belongs
Tel: +44 (0) 1903 288262
to CMP. It is indexed/abstracted in MEDLINE/Index Medicus,
Fax: +44 (0) 1903 234862
EMBASE and SIMID.
E-mail:
[email protected]
34
The International MS Journal 2007; 14: 29–34
●
Notes for Authors
Peer Review
Drug Names: The World Health Organization International Non-
Articles may be provocative and challenging, but this should not
Proprietary names for drugs should be used. This may be followed
be at the expense of scientific accuracy. All articles will be subject
by the proprietary name in parentheses at the first mention.
to two peer reviewers who are identified by the Editors-in-Chief of
Abbreviations: Abbreviate scientific units according to SI
the journal. The manuscript and review comments will be returned
criteria. Ensure that all other abbreviations are given in full at
to the authors for revision prior to manuscript acceptance.
their first mention and abbreviated consistently thereafter. Illustrations: The journal is a full-colour publication. Illustrations
Publishing Agreement and Copyright It is a requirement of publication that the copyright of all materials submitted is transferred to CMP. This does not affect the authors’ right to use any part of their material in other work authored by them, provided that full credit is given to the journal. It is the authors’ responsibility to ensure that copyright is cleared for publication throughout the world using any medium of communication (e.g. photographs and illustrations) on all materials submitted. Please submit, ideally via e-mail, relevant documentation giving permission to reproduce tables and figures from third-party sources. Contributions should be original; they should not have been published, be in press or be under consideration by another publication.
Types of Article Review Articles should comprise a maximum of 2500 words, up to 10 illustrations and 40 references. If your article is likely to be considerably longer or shorter than this please make special arrangements with the publisher. Please ensure that the primary author’s contact details (including fax and e-mail address, if possible) are clearly indicated on the title page. Commentaries should comprise a maximum of 1200 words. They are more a personal piece, supported with references, in which an expert discusses the relative merits or problems of a specific approach to treatment, diagnosis or another problem facing clinicians involved in MS.
Conflicts of Interest All potential conflicts of interest must be declared in your manuscript.
Manuscript Preparation Online Publication: Please remember that the journal is published online as well as in print. Article Style: Articles will be edited to journal style by CMP, with spelling according to the Oxford English Dictionary. A final version of the edited manuscript will be sent to the author for approval. Any amendments to text should be made at this stage, as only essential changes will be accepted when the page proofs have been produced. Title Page: The title should be concise and informative. Provide the initials and surnames of each author, together with the full name and address of the institution with which they are affiliated. Key Words: Please provide up to eight MESH compatible key words that will help bibliographic databases cross-reference your article effectively. Headings: For clarity, it is suggested that articles include no more than three levels of sub-heading.
The International MS Journal 2007; 14: 35
(figures and photographs) are especially welcome, particularly colour ones. Images should be supplied preferably as TIF, JPG or EPS files via e-mail separately from the main text at a resolution of at least 300 dpi and at the size they will be reproduced. If you are unsure, please forward your images for checking by CMP’s Graphics Department. In addition, please submit, ideally by e-mail, relevant documentation giving permission to reproduce figures from third-party sources. Each figure should be clearly labelled using Arabic numerals to correspond to consecutive placement in the text and should include a legend and keys as appropriate. Any micrographs should include scale bars. Please consider whether information contained in a table could be presented more effectively graphically. References should be cited numerically in the text according to their first appearance using superscript numbers immediately following the relevant text and after any punctuation. They should be listed in the same order in the References section and styled per examples, including up to six authors’ names and using journal abbreviations as listed in Index Medicus, e.g. Journal: 1. Jones P, Smith A, Brown J, Davis P, Williams R, Roberts S et al. The epidemiology of MS. Int J Epidemiol 1994; 13: 381 – 390. Book chapter: 2. Smith P. Dietary impact of MS. In: Multiple Sclerosis. Brown J (ed). Worthing: Cambridge Medical Publications, 1994; pp9 – 11. Webpage: 3. AMB Community. Serono Identifies 80 Genes Involved in Multiple Sclerosis Using 100,000 SNPs. Available at: http://microarraybulletin.com/community/?=17. Last accessed 20 May 2007. Abstracts: 4. Schacker T, Ryncarz A, Goddard J et al. Frequent recovery of HIV from genital herpes simplex virus lesions in HIVinfected persons (abstract). 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, USA, 1996. Only references accepted by a journal should be included in the reference list. Data on file, personal communications or content submitted but not yet accepted should be shown in text as follows: (Biron K, personal communication, 2002). If you have used bibliographic software for producing your reference list (e.g. EndNote or Reference Manager), it is essential that you unlink your reference list before submitting your completed manuscript to the journal.
35
